| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| NGM BIOPHARMACEUTICALS INC | Chief Financial Officer | Common Stock | 0 | $0 | $1.34 | 05 Apr 2024 | Direct |
| SpyGlass Pharma, Inc. | Chief Financial Officer | Stock Option (right to buy) | 17,500 | 05 Feb 2026 | Direct | ||
| NGM BIOPHARMACEUTICALS INC | Chief Financial Officer | Stock Option (Right to Buy) | 0 | 05 Apr 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| SGP | SpyGlass Pharma, Inc. | 05 Feb 2026 | 1 | $0 | 4 | Chief Financial Officer | 09 Feb 2026, 16:40 |
| SGP | SpyGlass Pharma, Inc. | 05 Feb 2026 | 0 | $0 | 3 | Chief Financial Officer | 05 Feb 2026, 13:02 |
| /report/000095017024042611-viret-jean-frederic-2024-03-26 | NGM BIOPHARMACEUTICALS INC | 26 Mar 2024 | 2 | $0 | 4 | Chief Financial Officer | 08 Apr 2024, 16:14 |
| /report/000120919123057214-viret-jean-frederic-2023-12-01 | NGM BIOPHARMACEUTICALS INC | 01 Dec 2023 | 1 | $0 | 4 | Chief Financial Officer | 04 Dec 2023, 16:27 |
| /report/000120919123054736-viret-jean-frederic-2023-11-03 | NGM BIOPHARMACEUTICALS INC | 03 Nov 2023 | 0 | $0 | 3 | Chief Financial Officer | 08 Nov 2023, 18:13 |